Inhibrx Biosciences
Price & Volume
Stats
See more52W Range | $10.84-$94.56 |
Market Cap | $1B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $1.3M |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$111.7M |
Diluted EPS | -$9.04 |
News
See moreYahoo Finance • 6 days ago
Inhibrx gains as Stifel issues new Buy based on lead assets
Yahoo Finance • 6 days ago
Coinbase downgraded, Deere upgraded: Wall Street's top analyst calls
Yahoo Finance • 8 months ago
Countdown To October: Inhibrx Awaits Ozekibart Clinical Data
Yahoo Finance • 8 months ago
Inhibrx Biosciences GAAP EPS of -$1.85, revenue of $1.3M
About
CEO | Mr. Mark Paul Lappe |
CFO | Ms. Kelly Devine Deck B.S., CPA, M.S. |
Address | 11025 North Torrey Pines Road, La Jolla, CA, United States, 92037 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 109 |
